Campath and malignant neoplasm progression Patient Reports February 11, 2012

Campath Side Effects Report #4750402-9
Campath side effect was reported by a Physician from UNITED STATES on Aug 04, 2005. Male patient, 76 years of age, weighting 203.9 lb, was diagnosed with t-cell chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, jaundice , malignant neoplasm progression, neutropenia, subarachnoid haemorrhage, t-cell chronic lymphocytic leukaemia. Campath dosage: 30 MG, 3X/WEEK MONTHLY, SUBCUTANEOUS; 30 MG, 3X/WEEK MONTHLY, SUBCUTANEOUS; 3/10/30MG, SUBCUTANEOUE. During the same period patient was treated with PROSCAR, ACYCLOVIR, FOLIC ACID, BACTRIM DS, BENADRYL ACHE, TYLENOL. Patient was hospitalized. Patient died on 07/13/2005.

Campath Side Effects Report #4668405-1
Campath side effect was reported by a Physician from on May 09, 2005. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia stage 4 and was treated with Campath. After drug was administered, patient experienced the following side effects: chronic lymphocytic leukaemia, inappropriate antidiuretic hormone secretion, malignant neoplasm progression, oedema peripheral. Campath dosage: unknown. During the same period patient was treated with CHLORIDE. Patient was hospitalized. Patient died on 01/01/2003.

Campath Side Effects Report #4694966-2
Campath side effect was reported by a Physician from on Aug 25, 2004. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia stage 4 and was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Campath dosage: unknown. During the same period patient was treated with FLUDARA. Patient died on 01/01/2004.

Campath Side Effects Report #4712636-9
Campath side effect was reported by a Physician from UNITED STATES on Aug 25, 2004. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia stage 4 and was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Campath dosage: unknown. During the same period patient was treated with FLUDARA. Patient died on 01/01/2004.


Campath Side Effects Report #4822183-1
Campath side effect was reported by a Physician from UNITED STATES on Oct 20, 2005. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia stage 4 and was treated with Campath. After drug was administered, patient experienced the following side effects: chronic lymphocytic leukaemia, confusional state, fatigue, inappropriate antidiuretic hormone secretion, inferior vena caval occlusion, lymphadenopathy, lymphoedema, malignant neoplasm progression, nausea . Campath dosage: 30 MG, 3X/WEEK (M,W,F), INTRAVENOUS. During the same period patient was treated with SALINE, RABEPRAZOLE, TERAZOSIN, SEPTRA DS, ACYCLOVIR, FLUTICASONE, DOCUSATE, EPOGEN. Patient was hospitalized. Patient died on 01/01/2003.

Campath Side Effects Report #5024003-1
Campath side effect was reported by a Health Professional from UNITED STATES on May 31, 2006. Female patient, 83 years of age, weighting 116.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: anaemia, cerebral atrophy, inappropriate antidiuretic hormone secretion, lymphocytic leukaemia, malignant neoplasm progression, malnutrition, nausea , pneumonia , pulmonary mass. Campath dosage: unknown. During the same period patient was treated with LISINOPRIL W, PLE VITAMINS, BENADRYL, TYLENOL, SULFAMETOXAZOL MED TRIMETOPRIM, FAMCICLOVIR. Patient was hospitalized. Patient died on 04/04/2005.

Campath Side Effects Report #5635548-5
Campath side effect was reported by a Physician from AUSTRIA on Feb 18, 2008. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia, multiple myeloma  and was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , paraproteinaemia, pneumonia . Campath dosage: unknown. During the same period patient was treated with BENDAMUSTINE. Patient died on 09/30/2006.

Campath Side Effects Report #6005849-X
Campath side effect was reported by a Physician from AUSTRIA on Dec 02, 2008. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia, multiple myeloma  and was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , paraproteinaemia, pneumonia . Campath dosage: unknown. During the same period patient was treated with BENDAMUSTINE. Patient died on 09/30/2006.

Campath Side Effects Report #6004345-3
Campath side effect was reported by a Consumer or non-health professional from AUSTRIA on Dec 02, 2008. Male patient, 69 years of age, was diagnosed with chronic lymphocytic leukaemia, infection prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: chronic lymphocytic leukaemia, malignant neoplasm progression, pulmonary tuberculosis, squamous cell carcinoma. Campath dosage: UNIT DOSE: 3 MG. During the same period patient was treated with VALACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient died on 07/25/2003.


Campath Side Effects Report #5085332-9
Campath side effect was reported by a Physician from UNITED KINGDOM on Aug 07, 2006. Male patient, 68 years of age, weighting 220.5 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: atrioventricular block second degree, atrioventricular block third degree, bradycardia, chronic lymphocytic leukaemia, fall , malignant neoplasm progression, nosocomial infection. Campath dosage: 30 MG, 3X/WEEK, SUBCUTANEOUS. During the same period patient was treated with ACYCLOVIR, AMILORIDE, BUMETANIDE, LANSOPRAZOLE, PREDNISOLONE, ITRACONAZOLE. Patient was hospitalized. Patient died on 04/10/2006.

Campath Side Effects Report #5044248-4
Campath side effect was reported by a Physician from SWEDEN on June 28, 2006. Male patient, 64 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: chemical cystitis, cystitis haemorrhagic, inflammation, malignant neoplasm progression, pain , pulmonary mycosis. Campath dosage: 30 MG, 3X/WEEK, INTRAVENOUS. During the same period patient was treated with DIFLUCAN, LEVOTHYROXINE, DIGOXIN, BEHEPAN COATED, EUSAPRIMTE, ALLOPURINOL, GEAVIR. Patient was hospitalized. Patient died.

Campath Side Effects Report #4712672-2
Campath side effect was reported by a Physician from UNITED STATES on Apr 11, 2005. Female patient, 52 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: anaemia, bacteria blood identified, diarrhoea, febrile neutropenia, malignant neoplasm progression. Campath dosage: 30 MG, MAINTENANCE, Q3MOS, SUBCUTANEOUS. During the same period patient was treated with BACTRIM DS, ACYCLOVIR, ALLOPURINOL, VITAMINS. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5697926-8
Campath side effect was reported by a Physician from UNITED STATES on Apr 04, 2008. Female patient, 55 years of age, weighting 154.3 lb, was diagnosed with adult t-cell lymphoma/leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: adult t-cell lymphoma/leukaemia, atrial fibrillation , blood amylase increased, blood triglycerides increased, bone marrow failure, febrile neutropenia, malignant neoplasm progression, nonspecific reaction, pancytopenia. Campath dosage: 30MG THREE TIMES A WEEK IV DRIP. Patient recovered.

Campath Side Effects Report #5384046-5
Campath side effect was reported by a Health Professional from UNITED STATES on May 03, 2007. Male patient, 44 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Campath dosage: unknown. Patient died on 02/26/2007.


Campath Side Effects Report #5320746-0
Campath side effect was reported by a Consumer or non-health professional from AUSTRIA on Apr 28, 2007. Male patient, 72 years of age, was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, multiple myeloma , paraproteinaemia. Campath dosage: unknown. Patient died on 09/30/2006.

Campath Side Effects Report #5374401-1
Campath side effect was reported by a Physician from UNITED STATES on June 22, 2007. Female patient, 64 years of age, weighting 142.0 lb, was diagnosed with wolff-parkinson-white syndrome, infection prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: diarrhoea, injection site infection, malignant neoplasm progression, mycobacterium chelonei infection. Campath dosage: unknown. During the same period patient was treated with PREVACID, TENORMIN, ACYCLOVIR, BACTRIM, PYRIDIUM. Patient died on 01/01/2007.

Campath Side Effects Report #5100736-3
Campath side effect was reported by a Physician from UNITED STATES on Aug 22, 2006. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dialysis , hodgkin's disease , lung infection, malignant neoplasm progression, platelet count decreased, pleural effusion, pulmonary haemorrhage. Campath dosage: 50 MG, D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, MESNA. Patient was hospitalized. Patient died on 08/10/2006.

Campath Side Effects Report #5105185-X
Campath side effect was reported by a Physician from UNITED STATES on Sept 05, 2006. Female patient, 38 years of age, was diagnosed with prophylaxis and was treated with Campath. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, lung infection, malignant neoplasm progression, myopathy steroid, pleural effusion, pulmonary haemorrhage, renal failure, respiratory failure. Campath dosage: 50 MG, D-7 TO D-3, INTRAVENOUS. During the same period patient was treated with FLUDARA, CYCLOPHOSPHAMIDE, MESNA, BACTRIM, MS CONTIN, VICODIN, MS CONTIN, LEVOTHYROXINE. Patient was hospitalized. Patient died on 08/10/2006.

Campath Side Effects Report #5360856-5
Campath side effect was reported by a Pharmacist from UNITED KINGDOM on June 12, 2007. Male patient was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Campath dosage: 30 MG X3D PRIOR TO ICE TX. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient died.


Campath Side Effects Report #5376530-5
Campath side effect was reported by a Pharmacist from UNITED KINGDOM on June 26, 2007. Male patient was treated with Campath. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Campath dosage: 30 MG X3D PRIOR TO ICE TX. During the same period patient was treated with IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE. Patient died on 01/01/2007.

Campath Side Effects Report #5478621-7
Campath side effect was reported by a Health Professional from UNITED KINGDOM on Oct 01, 2007. Male patient was treated with Campath. After drug was administered, patient experienced the following side effects: infection , malignant neoplasm progression. Campath dosage: unknown. Patient died on 01/01/2007.